Biogen Stock Options Expiring on 17th of October
| BIIB Stock | USD 123.75 0.00 0.00% |
Biogen's latest option contracts expiring on October 17th 2025 are carrying combined implied volatility of 0.51 with a put-to-call open interest ratio of 0.69 over 56 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on October 17th 2025. The total put volume is at 80.0, with calls trading at the volume of 66.0. This yields a 1.21 put-to-call volume ratio.
Open Interest Against October 17th 2025 Option Contracts
2025-10-17
The chart above shows Biogen's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Biogen's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Biogen's option, there is no secondary market available for investors to trade.
Biogen Maximum Pain Price Across 2025-10-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Biogen close to expiration to expire worthless. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, Biogen's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Biogen's stock options are financial instruments that give investors the right to buy or sell shares of Biogen Inc common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Biogen stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Biogen's stock price goes up or down, the stock options follow.
At present, Biogen's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 29.5 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 138.6 M. Biogen Inc In The Money Call Balance
When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying Biogen's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Biogen Inc are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Biogen Current Options Market Mood
Biogen's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Biogen Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Biogen's options investors are not very successful. Biogen's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Biogen contract
Base on the Rule 16, the options market is currently suggesting that Biogen Inc will have an average daily up or down price movement of about 0.0319% per day over the life of the 2025-10-17 option contract. With Biogen trading at USD 123.75, that is roughly USD 0.0394. If you think that the market is fully incorporating Biogen's daily price movement you should consider buying Biogen Inc options at the current volatility level of 0.51%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Biogen Option Chain
When Biogen's strike price is surpassing the current stock price, the option contract against Biogen Inc stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Biogen's option chain is a display of a range of information that helps investors for ways to trade options on Biogen. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Biogen. It also shows strike prices and maturity days for a Biogen against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | BIIB251017C00230000 | 1 | 230.0 | 0.0 - 2.15 | 2.15 | Out |
Call | BIIB251017C00220000 | 1 | 220.0 | 0.0 - 2.2 | 2.2 | Out |
Call | BIIB251017C00210000 | 6 | 210.0 | 0.05 - 0.75 | 0.21 | Out |
Call | BIIB251017C00200000 | 10 | 200.0 | 0.0 - 2.25 | 1.22 | Out |
Call | BIIB251017C00195000 | 58 | 195.0 | 0.0 - 2.3 | 0.9 | Out |
Call | BIIB251017C00190000 | 27 | 190.0 | 0.0 - 2.35 | 1.6 | Out |
Call | BIIB251017C00185000 | 21 | 185.0 | 0.0 - 2.4 | 2.4 | Out |
Call | BIIB251017C00180000 | 45 | 180.0 | 0.0 - 2.5 | 2.83 | Out |
Call | BIIB251017C00175000 | 14 | 175.0 | 0.0 - 2.6 | 0.91 | Out |
Call | BIIB251017C00170000 | 46 | 170.0 | 0.0 - 2.7 | 1.25 | Out |
Call | BIIB251017C00165000 | 60 | 165.0 | 0.5 - 1.6 | 2.38 | Out |
Call | BIIB251017C00160000 | 94 | 160.0 | 0.0 - 1.65 | 1.5 | Out |
Call | BIIB251017C00155000 | 166 | 155.0 | 1.1 - 1.65 | 1.3 | Out |
Call | BIIB251017C00150000 | 183 | 150.0 | 1.5 - 2.3 | 3.0 | Out |
Call | BIIB251017C00145000 | 159 | 145.0 | 2.25 - 2.9 | 2.85 | Out |
Call | BIIB251017C00140000 | 159 | 140.0 | 3.2 - 3.9 | 4.11 | Out |
Call | BIIB251017C00135000 | 190 | 135.0 | 4.6 - 5.3 | 6.7 | Out |
Call | BIIB251017C00130000 | 117 | 130.0 | 6.4 - 7.0 | 6.77 | Out |
Call | BIIB251017C00125000 | 17 | 125.0 | 6.9 - 10.9 | 16.4 | Out |
Call | BIIB251017C00120000 | 17 | 120.0 | 11.4 - 12.2 | 11.52 | In |
Call | BIIB251017C00115000 | 21 | 115.0 | 13.6 - 17.2 | 18.8 | In |
Call | BIIB251017C00110000 | 1 | 110.0 | 16.9 - 20.7 | 16.9 | In |
Call | BIIB251017C00100000 | 1 | 100.0 | 25.3 - 29.2 | 30.93 | In |
Call | BIIB251017C00080000 | 20 | 80.0 | 44.2 - 48.4 | 49.19 | In |
Call | BIIB251017C00075000 | 10 | 75.0 | 49.3 - 53.3 | 63.7 | In |
Call | BIIB251017C00070000 | 24 | 70.0 | 54.1 - 58.2 | 59.91 | In |
Put | BIIB251017P00065000 | 11 | 65.0 | 0.0 - 2.3 | 1.21 | Out |
Put | BIIB251017P00070000 | 5 | 70.0 | 0.0 - 2.3 | 0.78 | Out |
Put | BIIB251017P00075000 | 21 | 75.0 | 0.0 - 2.3 | 0.65 | Out |
Put | BIIB251017P00080000 | 5 | 80.0 | 0.0 - 2.35 | 0.88 | Out |
Put | BIIB251017P00085000 | 21 | 85.0 | 0.0 - 1.5 | 1.26 | Out |
Put | BIIB251017P00090000 | 5 | 90.0 | 0.0 - 2.55 | 2.55 | Out |
Put | BIIB251017P00095000 | 46 | 95.0 | 0.0 - 1.05 | 1.5 | Out |
Put | BIIB251017P00100000 | 295 | 100.0 | 0.0 - 1.2 | 2.0 | Out |
Put | BIIB251017P00105000 | 47 | 105.0 | 0.1 - 2.1 | 1.5 | Out |
Put | BIIB251017P00110000 | 47 | 110.0 | 0.95 - 3.1 | 2.23 | Out |
Put | BIIB251017P00115000 | 86 | 115.0 | 3.4 - 3.8 | 3.6 | Out |
Put | BIIB251017P00120000 | 42 | 120.0 | 4.3 - 5.5 | 4.5 | Out |
Put | BIIB251017P00125000 | 140 | 125.0 | 7.2 - 7.8 | 7.4 | Out |
Put | BIIB251017P00130000 | 104 | 130.0 | 9.7 - 12.3 | 10.2 | In |
Put | BIIB251017P00135000 | 32 | 135.0 | 13.0 - 15.6 | 12.63 | In |
Put | BIIB251017P00140000 | 40 | 140.0 | 16.0 - 19.3 | 15.4 | In |
Put | BIIB251017P00145000 | 45 | 145.0 | 19.4 - 23.4 | 16.37 | In |
Put | BIIB251017P00150000 | 19 | 150.0 | 23.8 - 27.8 | 23.56 | In |
Put | BIIB251017P00160000 | 6 | 160.0 | 33.2 - 37.2 | 27.53 | In |
Put | BIIB251017P00165000 | 1 | 165.0 | 38.0 - 42.0 | 38.0 | In |
Put | BIIB251017P00170000 | 0 | 170.0 | 42.8 - 47.1 | 42.8 | In |
Put | BIIB251017P00175000 | 0 | 175.0 | 47.8 - 52.0 | 47.8 | In |
Put | BIIB251017P00180000 | 0 | 180.0 | 52.8 - 57.1 | 52.8 | In |
Put | BIIB251017P00185000 | 0 | 185.0 | 57.8 - 62.1 | 57.8 | In |
Put | BIIB251017P00190000 | 0 | 190.0 | 62.8 - 67.1 | 62.8 | In |
Put | BIIB251017P00195000 | 0 | 195.0 | 67.8 - 72.1 | 67.8 | In |
Put | BIIB251017P00200000 | 0 | 200.0 | 72.8 - 77.1 | 72.8 | In |
Put | BIIB251017P00210000 | 0 | 210.0 | 82.8 - 87.1 | 82.8 | In |
Put | BIIB251017P00220000 | 0 | 220.0 | 92.8 - 97.1 | 92.8 | In |
Put | BIIB251017P00230000 | 0 | 230.0 | 102.8 - 107.1 | 102.8 | In |
Biogen Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Biogen Total Stockholder Equity
Total Stockholder Equity |
|
Biogen Corporate Executives
Elected by the shareholders, the Biogen's board of directors comprises two types of representatives: Biogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biogen. The board's role is to monitor Biogen's management team and ensure that shareholders' interests are well served. Biogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael CPA | Executive CFO | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.39) | Earnings Share 10.12 | Revenue Per Share | Quarterly Revenue Growth 0.061 | Return On Assets |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.